-
Product Insights
Arterial Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Arterial thrombosis pipeline market report provides a comprehensive overview on the therapeutics under development for Arterial thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Arterial thrombosis and features dormant...
-
Product Insights
Deep Vein Thrombosis (DVT) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Deep Vein Thrombosis Pipeline Drugs Market Overview Deep venous thrombosis is a blood clot that forms in a vein deep inside a part of the body. It mainly affects the large veins in the lower leg and thigh. Symptoms include changes in skin color (redness), leg pain, leg swelling (edema), and skin that feels warm to the touch. The predisposing factors include age, smoking, inheriting a blood-clotting disorder, injury or surgery, cancer, inflammatory bowel disease, and heart failure. Treatment includes...
-
Product Insights
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pulmonary arterial hypertension pipeline market research report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Arterial Hypertension and...
-
Product Insights
Raynauds Disease - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report provides data on the Raynaud disease clinical trial scenario. This report provides top-line data relating to the clinical trials on Raynaud Disease. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based...
-
Product Insights
Diastolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Diastolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Diastolic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diastolic Heart Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2016" provides an overview of Tachycardia (Tachyarrhythmias) clinical trials scenario. This report provides top line data relating to the clinical trials on Tachycardia (Tachyarrhythmias). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical trials on Deep Vein Thrombosis (DVT). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Hemorrhagic Shock Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, H1, 2016" provides an overview of Hemorrhagic Shock clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhagic Shock. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Phlebitis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Phlebitis Global Clinical Trials Review, H1, 2016" provides an overview of Phlebitis clinical trials scenario. This report provides top line data relating to the clinical trials on Phlebitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.